Regulatory/program MGT/admin support
Active Definitive Contract Awarded Last action
- Contract number
- W81XWH15C0048
- Awardee
-
Westat, Inc. UEI NVUWAFWQ57S5
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $22,214,369
Award facts
- Opportunity
-
- W81XWH14R0059 Solicitation number
- Performance of Good Clinical Practices (GCP) Compliant Clinical Trials of a Freeze Dried Plasma (FDP) Product of Support Efforts to Obtain Food and Drug Administration (FDA) Licensure Award Notice · Posted Jun 13, 2014
- Contract value 78% obligated
-
- $23,174,896.00 Current, with exercised options
- $28,596,517.00 Potential, with all options
- Completion date 98% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | -$534,055 | |
| Change Order | $4,079,886 | |
| Change Order | $2,474,344 | |
| Funding Only Action | $0 | |
| Funding Only Action | $239,770 | |
| Additional Work (new agreement, FAR part 6 applies) | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $5,258,984 | |
| Funding Only Action | -$1,733,855 | |
| Change Order | $2,864,030 | |
| Funding Only Action | $498,000 | |
| Funding Only Action | $300,000 | |
| Change Order | $0 | |
| Funding Only Action | $1,824,467 | |
| Exercise an Option | $930,845 | |
| Funding Only Action | -$840,621 | |
| Funding Only Action | $490,616 | |
| Funding Only Action | $912,423 | |
| Exercise an Option | $840,621 | |
| Funding Only Action | $160,000 | |
| Funding Only Action | $500,000 | |
| Funding Only Action | $250,000 | |
| Funding Only Action | $500,000 | |
| Funding Only Action | $1,243,385 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $1,955,529 |
Show all 29
About this award
The Defense Health Agency awarded a definitive contract to Westat, Inc. for regulatory, program management, and administrative support related to commercialization of freeze-dried plasma product on March 30, 2015, with a ceiling value of $28.6 million.
The contract carries a cost-plus-fixed-fee pricing structure and no set-aside category. Place of performance is Rockville, MD. The ultimate completion date is December 31, 2026.
Quick answers
Who was awarded contract W81XWH15C0048?
W81XWH15C0048 was awarded to Westat, Inc. by Defense Health Agency (Department of Defense) on March 30, 2015.
How much is contract W81XWH15C0048 worth?
The government has obligated $22,214,369 on W81XWH15C0048. Its current value, with exercised options, is $23,174,896. Its potential value, with all options, is $28,596,517.
Was contract W81XWH15C0048 competed?
The extent of competition for W81XWH15C0048 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award